Health and Fitness, is important to living a healthy life. Learn the newest research from our Press Releases today.
SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active Crohn’s disease who have failed one or more anti-TNFs1 Risankizumab met both primary endpoints of non-inferiority for clinical remissiona…
“This is a great example of next-best-action at scale,” says Insightin Health founder and CEO, Enam Noor. “As members complete a digital HRA, the inGAGE™ platform identifies and automates member-specific outreach through our partnership with Drips.”
Most health plans are capturing this valuable information from their members today, however, without automation tools they are constrained by human capital and forced to focus on smaller segments of their population. Noor describes what he sees as a true win-win: “With inGAGE™ as the “brain” and Drips as the engagement “muscle,” health plans can save money while improving member satisfaction.”
“To help payers improve member experience and health outcomes, it’s not enough to just have data or just have an outreach platform,” said Drips Managing Director of Healthcare Dan Fox. “You need both of these things working hand in hand. By combining the inGAGE™ automation platform with Drips conversational outreach, we’ve created a truly remarkable solution that is transforming the way payers handle HRAs.”
About Drips
With AI-powered text messaging, scheduled calling, and voicemail messages, Drips helps major healthcare brands drive real two-way conversations at scale at critical moments in the consumer journey. Backed by a proprietary natural language processing model, Drips’ conversational outreach strategy empowers health plan members and patients to engage on their own terms, leading to better results.
Drips has handled over 1.5 billion conversations for some of the world’s biggest brands. Top payers and brokers use Drips to improve engagement, member satisfaction, and outcomes across a wide variety of healthcare use cases. Learn more at www.drips.com or connect via LinkedIn.
About Insightin Health
Insightin Health helps healthcare payers eliminate data silos and deliver highly satisfying consumer-centric experiences. inGAGE™ — their software as a service (SaaS) platform — is the industry leading solution for improving experience and satisfaction. Using artificial intelligence and machine learning, inGAGE™ leverages the totality of the connected data, in real-time, to produce insights that drive Next Best Action (NBA) workflows to solve pressing healthcare challenges. inGAGE™ allows healthcare payers to increase lifetime member value, drive growth, and improve overall plan profitability. Learn more at www.insightinhealth.com or connect via LinkedIn.
Media Contact
Marcia Kepler, Insightin Health, 1 888-5240-6744, [email protected], www.insightinhealth.com
SOURCE Insightin Health
The PathKeeper System was designed to replace traditional navigation technology with an active, independent and precise 3D optical navigation system. It offers tracking and registration accuracy to less than 1mm, an efficient surgical workflow from planning to post-operative analysis, elimination of radiation exposure during the surgical procedure and a more economical price so both the hospital and ambulatory surgical center operating rooms can incorporate this new technology.
“The United States represents a strategically important market for commercializing the PathKeeper System and the NASS annual meeting is the ideal environment to demonstrate our technology to spine surgeons from the United States and around the world,” said Erez Lampert, Chief Executive Officer and Founder of PathKeeper Surgical.
PathKeeper Surgical received its FDA 510k clearance earlier this year for the PathKeeper System. The name PathKeeper effectively describes the essence of the system – a 3D optical navigation system that ‘keeps’ the surgical ‘path’ on course throughout the surgery. Learn more at https://www.path-keeper.com.
About PathKeeper Surgical
PathKeeper Surgical is an Israeli-based, medical technology company that has established a solution to combat the high failure rates seen in spinal surgeries. PathKeeper was founded in 2018 by Erez Lampert, a top 3D medical imaging expert with more than 20 years of experience in the healthcare and aerospace industries, and a proven track record in the field of 3D imaging. Erez previously served as the R&D leader for the Itero Element Intraoral Scanner for Align Technology (Invisalign), the leading 3D dental scanner in the world today. Josh Schroeder, MD, the Director of Spinal Deformities at Hadassah Medical Center and a HSS fellow, has been onboard since the inception of the company as a clinical advisor. Erez and Josh’s combined knowledge and experience enabled the company to develop an innovative navigation system that outperforms existing solutions. For more information, go to https://www.path-keeper.com.
Media Contact
Ryan LeBlanc, PathKeeper Surgical, 1 860-334-6493, [email protected], https://www.path-keeper.com
SOURCE PathKeeper Surgical
Day 1: Fundamental Insights and Pre-clinical Tools
The first day of the Summit centered on the fundamental science of MECP2 and available and emerging pre-clinical tools, setting the stage for a deeper understanding of the molecular mechanisms underlying Rett syndrome and discussion of scientific resources to facilitate IND-enabling studies.
Adrian Bird, PhD, a distinguished scientist and luminary in the field, gave a keynote address focused on understanding the molecular basis of Rett syndrome. Experts in the field shared research findings and novel available tools, laying the groundwork for further exploration and therapeutic development.
Contributions from the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) revealed the agency’s approach to evaluating IND submissions in a robust panel discussion moderated by Philip (PJ) Brooks, Deputy Director of the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences at the National Institutes of Health.
Day 2: Exploring Genetic Medicine Modalities and the Evolving Regulatory Landscape
The second day of the summit delved into various genetic medicine modalities, including gene therapy, DNA base editing, prime editing, RNA editing, MECP2 reactivation and transfer RNA. Sukumar Nagendran, MD, President of Taysha Gene Therapies, presented encouraging data on the first patient treated with their Rett syndrome gene therapy. Stuart Cobb, PhD, Chief Scientific Officer of Neurogene provided an update on the company’s gene therapy clinical trial.
Distinguished speakers, including David Liu, PhD, from the Broad Institute at MIT and Harvard University and co-founder of numerous biotech companies, spoke on the future of base and prime editing and their application in treating genetic diseases.
Peter Marks, MD, the Director of CBER at FDA and prominent figure in the field of regulatory science presented on the evolving regulatory landscape for biologic therapeutics in orphan diseases. A panel discussion focused on agency expectations, accelerated approval requirements, and other key elements of successful development programs was moderated by Frank Sasinowski, MS, MPH, JD, a regulatory affairs and drug development expert and Director at Hyman, Phelps & McNamara, P.C.
Day 3: Advancements in Clinical Development Tools
The final day of the summit focused on novel clinical development tools, encompassing outcome assessments, digital biomarkers, and RSRT’s CURETT initiative. Day 3 opened with a keynote address from renowned physician scientist, Huda Zoghbi, MD, who spoke on modulating MECP2 levels for a novel therapeutic approach.
Lindsey Murray, MPH, PhD, Executive Director, Rare Disease Clinical Outcome Assessment (COA) Consortium at the Critical Path Institute, and Christopher Leptak, MD, PhD, Executive VP of Drug and Biological Products at Greenleaf Health, moderated panels on COAs and digital biomarkers. The discussions provided insights on how best to implement fit-for-purpose and adapted COAs in Rett, and demonstrated the latest advances in objective digital measures including EEG, wearable and invisible sensors, and how these measures track with clinician-reported disease severity scales.
Nasha Fitter, VP of Patient Data Platform, Ciitizen moderated the real-world data session with presentations on the Ciitizen platform and RSRT’s CURETT initiative. CURETT is a parent-powered initiative to Combine Untapped Resources to Expedite Targeted Therapeutics by consolidating medical records and parent-reported datasets for use in therapeutic development with promising potential to serve as an external control for Rett syndrome development programs.
RSRT’s Rett Syndrome Genetic Medicines Summit underscores the organization’s unwavering commitment to curing Rett syndrome. Uniting the scientific and biotechnology communities and facilitating knowledge exchange is key to achieving that. “We are deeply encouraged by the unprecedented collaboration among scientists, clinicians, and industry leaders that unfolded during these three remarkable days that will lead to efficiencies in development and regulatory interactions,” said Monica Coenraads, RSRT’s CEO. “Together, we are poised to make major strides to expedite clinical development and transform the lives of those with Rett.”
The Rett Syndrome Research Trust extends its gratitude to all the participants, speakers, moderators, panelists and sponsors who contributed to the success of the inaugural event. The exciting progress in the field and overall success of the meeting would not have occurred without RSRT’s generous supporters and the fundraising efforts of Rett families. RSRT remains steadfast in its mission to accelerate the development of genetic therapies and ultimately find a cure for Rett syndrome.
For more information on the Rett Syndrome Genetic Medicines Summit please visit https://reverserett.org/research/for-researchers/rett-syndrome-genetic-medicines-summit/
ABOUT THE RETT SYNDROME RESEARCH TRUST
RSRT is a nonprofit organization with a highly personal and urgent mission: achieving a cure for Rett syndrome and related disorders caused by defects in the MECP2 gene. Since its founding in 2008, RSRT has awarded more funds than any other Rett organization in the world, to leading scientists pursuing targeted research on Rett. RSRT funds and spearheads global scientific and clinical activities advancing the most promising curative approaches. To date, every biopharmaceutical company pursuing a cure for Rett syndrome is doing so because they leveraged discoveries and resources incubated with RSRT funding. To learn more, please visit www.reverserett.org.
Media Contact
Monica Coenraads, Rett Syndrome Research Trust, 1 2034450041, [email protected], https://reverserett.org/
SOURCE Rett Syndrome Research Trust
Before joining MedReview, Diehl served as Vice President of Client Delivery at Conifer Health Solutions, where he provided client executive and strategy leadership for revenue cycle management and product sales to large health systems. He was also responsible for all aspects of program growth initiatives. Prior to that, he was Vice President of Account Management at Discovery Health Systems, where he redesigned compliance and analytics protocols for greater efficiency and transparency and managed a portfolio of more than 35 health plan accounts. Diehl also spent seven years at Health Management Systems as Vice President of State Government Services
Diehl has a bachelor’s of science in business accounting and information systems
from the University of Idaho, and a master’s of business administration, with an emphasis on healthcare administration, from Baylor University.
About MedReview
Headquartered in the financial district of New York City and serving all U.S. states and territories, MedReview has been a leading provider of payment integrity, utilization management and quality surveillance services for more than 40 years. A physician-led organization with a passion for ensuring that health care claims fairly represent the care provided, MedReview provides timely independent hospital billing audits and clinical validation reviews on behalf of health plans, government agencies and Taft-Hartley organizations, saving millions of dollars for its clients each year.
Media Contact
Tracey Osentoski, MedReview, 248-977-0940, [email protected], www.medreview.us
SOURCE MedReview
“We are delighted to partner with Availity. Together, we afford providers added value within Availity’s robust Essentials network,” said RevSpring CEO Scott MacKenzie. “RevSpring’s state-of-the-art technology will help ensure Availity’s customers remain highly competitive as they take and process billions of financial transactions in the most streamlined and efficient way possible.”
“With this Availity-RevSpring collaboration, our national network of providers can now access sophisticated payment and merchant services solutions from within the Availity platform for a more efficient experience,” said Availity CEO Russ Thomas.
Other key features of RevSpring’s payment and merchant services include:
RevSpring and Availity share a strong commitment to collaboration that provides a better, more robust, and easier overall provider and patient payment experience.
About Availity
Availity is the trusted partner for organizations seeking to realize the greatest value from clinical, administrative, and financial data. Positioned at the nexus of provider, health plan and consumer information, Availity develops scalable, innovative solutions for healthcare data acquisition, standardization, transparency, automation and exchange among health plans, providers, and technology partners. As one of the nation’s largest health information networks, Availity facilitates billions of clinical, administrative, and financial transactions annually. Its suite of dynamic products, built on a powerful, intelligent platform, enables real-time collaboration for success in a competitive, value-based care environment. For more information about Availity, please visit availity.com or call 1.800.AVAILITY (282.4548). Follow Availity on LinkedIn and X (formerly Twitter).
About RevSpring
RevSpring leads the market in healthcare engagement and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful patient engagement suite, spanning the clinical, operational and payment experience. RevSpring’s OmniChannel communications and payment solutions are backed by behavior analysis, propensity-to-pay scoring, contextual messaging and user experience best practices. Using proprietary data analytics to tailor the engagement from preservice to post-service, RevSpring improves the patient experience and outcomes for providers, members and patients. To learn more, visit revspringinc.com/healthcare. Follow RevSpring on LinkedIn and X (formerly Twitter).
Media Contact
Kristen Jacobsen, RevSpring, 7639235280, [email protected], www.revspringinc.com
Matt Schlossberg, Availity LLC, 904.538.5661, [email protected], www.availity.com
SOURCE RevSpring
Nashville-based Shearwater Health has trained and augmented care teams with remote and onsite clinicians since 1973, reducing the strain on the healthcare system. With a global workforce of more than 5,000 expertly trained, clinical resources supported by innovative technology and Six Sigma process excellence, Shearwater Health offers both remote and onsite clinical expertise that can be deployed rapidly and securely. The organization recruits and trains nurses in skills such as utilization management, care management, patient care, and revenue cycle and supports their careers through education including the US Nursing Licensure Exam.
“Jen brings extensive experience in HR management, driving transformational change with a significant focus on building effective HR programs,” said Tom Kendrot, chief executive officer of Shearwater Health. “Our continued impact addressing worldwide nursing shortages depends on attracting and retaining the best talent, both in the US and overseas. We are thrilled to welcome a leader like Jen to the team.”
About Shearwater Health
Shearwater Health provides teams of remote and onsite clinicians that expand the size and impact of clinical teams so that clients can focus on internal teams practicing at the peak of their license. From bedside to back-office, there are over 5,000 Shearwater clinicians solving medical and administrative problems every hour of every day all over the world. Shearwater combines clinical expertise with Six Sigma process excellence and RPA technology to improve healthcare outcomes. For more information, please visit https://shearwaterhealth.com/ or on Linked In.
Media Contact
Heather Rivenburg, Punching Nun Group, 1 703-216-3893, [email protected], https://punchingnungroup.com/
SOURCE Shearwater Health
“We recognize the human side of healthcare and clinician’s role in providing best-in-class patient care, which is why we create products suited to your clinical needs in this environment,” said Melanie Rosen, Sr. Marketing Manager, Perioperative Solutions. Rosen continued, “We are excited to showcase our complete perioperative solutions at ANESTHESIOLOGY® Annual Meeting and invite all attendees to stop by Booth 1026 in Moscone Center South and witness how we advance medical technologies to make healthcare more accessible.”
During the assembly, Mindray will offer multiple educational events presented by renowned anesthesia leaders. On Saturday at 12:30 pm, Mindray is sponsoring the Center Stage Feature Presentation by Daniel Talmor, MD MPH, presenting on Lung Protective Ventilation in the Operating Room. Mindray will also host Dr. Richard Teames and Basem J Abdelmalak, MD, FASA, SAMBA-F, on Saturday and Sunday in Booth 1026 for educational sessions.
Mindray understands the need for clinicians to deliver focused and efficient patient care in the Perioperative space. With over 30 years of experience, Mindray has deep-seated roots and a sole focus on the healthcare industry. Through years of innovation, Mindray offers a comprehensive portfolio of leading-edge solutions to meet the diverse demands of evolving patient populations. These innovative, accessible solutions offer sophisticated tools and technologies that offer meaningful innovation to drive impactful results, complementing clinical workflow and enhancing patient care in the operating room.
About Mindray
Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: medical imaging, patient monitoring and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in Silicon Valley, California, with additional facilities in major international markets around the world. For more information, please visit Mindray.com.
Media Contact
Sondra Kaufman, Mindray North America, 201.995.8047, [email protected]
SOURCE Mindray North America
In this webinar, the featured speakers will discuss key patient-relevant features to be included in this approach. They will also review the ways to define patient experience expectations to help increase patient preferences, how to generate evidence to support usability and safe use claims in regulatory processes and how to determine relevant patient key performance indicators (KPIs) to measure the solutions’ potential market fit.
Join Alira Health‘s patient engagement experts for a deep dive into patient centric co-design. Discover the key elements of a validated and measurable methodology that can help healthcare providers to solve patients’ unmet needs.
Join Raquel Navarro, Insights Manager, Roche Diabetes Care; Giulia Pierini, Associate Director, Consulting Patient Engagement, Alira Health; and Eduardo Perez-Guagnelli, Patient-Centric Co-Design Lead, Alira Health, for the live webinar on Monday, October 23, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit How to Co-Design Your Solution With Patients.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
The NotiSphere platform allows the company to quickly and efficiently disseminate important information about device recalls or design changes that impact the supply of reprocessed devices
SCOTTSDALE, Ariz., Oct. 6, 2023 /PRNewswire-PRWeb/ — Innovative Health, Inc. today announced that the company has entered into an agreement with NotiSphere to provide its hospital customers with effective communication about backorders, product recalls, original manufacturer design changes, and other market events with the potential to impact the hospital’s supply of reprocessed devices. In doing so, the company is helping to reduce the impact of disruptions in device supply, ensuring continued and reliable patient access to life-saving cardiology procedures.
Innovative Health’s cardiology-focused single-use device reprocessing program has revolutionized the practice of reprocessing with a barrier-breaking reprocessing technology development program that has resulted in FDA clearances for cardiology devices that were previously thought of as non-reprocessable. This has created a service offering unmatched in the industry in terms of device cost reductions and reductions in CO2 emissions.
A constant, predictable supply of reprocessed devices can be impacted by original manufacturer design changes and recalls that limit the supply of reprocessed devices or delays the reprocessing process. NotiSphere offers an innovative digital platform that directly connects medical device suppliers, such as Innovative Health, and healthcare organizations, enabling direct communication and management of medical device recalls and market events in real-time.
“NotiSphere’s platform solves an important problem for us,” said Rick Ferreira, CEO at Innovative Health. “Our customers don’t want to log into hundreds of platforms to see their supply situation. The NotiSphere platform enables efficient dissemination of critical supply information from all their suppliers. At the same time, our hospital customers need to know market events that impact reprocessed product supplies, as they depend on the savings they provide.”
NotiSphere enables focused communication, directly to those who need to know. Efficient communication through the platform shortens the time it takes to execute recalls, reduces the number of alerts received by an organization, and improves efficiency in managing the market disruption event, allowing providers to focus on patient safety rather than administrative processes.
“Innovative Health and other circular suppliers in healthcare are uniquely vulnerable to recalls and other external events that restrict the company’s ability to collect and return reprocessed products to their partner hospitals,” said Guillermo Ramas, CEO at NotiSphere. “Innovative Health again shows its industry leadership in prioritizing implementation of an efficient solution to this process, and we are thrilled to partner with Innovative Health to address their unique supply disruption situation through efficient communication.”
About NotiSphere
NotiSphere establishes direct connections between medical device suppliers and healthcare organizations, facilitating seamless communication and real-time management of a wide spectrum of medical device supply disruptions. Our vision is to transform how the healthcare industry manages supply chain challenges, significantly reducing processing times, cutting costs for medical device suppliers, and ushering in a new era of sustainability by minimizing the environmental impact of traditional industry processes.
About Innovative Health
Innovative Health is an advanced medical device reprocessing company that offers smarter utilization of medical devices in hospitals’ cardiology and electrophysiology programs.
Innovative Health
Lori Luechtefeld
[email protected]
(310) 210-4757
NotiSphere
Francesca Ferrari
[email protected]
(844) 732-2551
Media Contact
Lori Luechtefeld, WIT Strategy for Innovative Health, 310-210-4757, [email protected], https://innovative-health.com
SOURCE WIT Strategy for Innovative Health
